Nalaganje...
Biomarkers for Immune Checkpoint Inhibitors in Melanoma
Immune checkpoint inhibitors have now become a standard therapy for malignant melanoma. However, as immunotherapies are effective in only a limited number of patients, biomarker development remains one of the most important clinical challenges. Biomarkers predicting clinical benefit facilitate appro...
Shranjeno v:
| izdano v: | Front Oncol |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Frontiers Media S.A.
2018
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6058029/ https://ncbi.nlm.nih.gov/pubmed/30073150 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2018.00270 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|